A GLP-1 tsunami is headed for the vice industry. Good.
A new wave of cheap weight-loss drugs heralds an existential crisis for the sin economy
Add BT as a preferred source
THERE is a new breed on the rise among us – they look just like your childhood friends and long-time colleagues, but they are no longer the people you used to know.
They are turning up to brunch in athleisure wear, picking at their food and refusing dessert.
Even as their waistlines shrink, the tribe of obesity or GLP-1 drug users is rapidly expanding. Since 2020, prescriptions for drugs such as Wegovy, Ozempic and Mounjaro have more than tripled in the US alone.
TRENDING NOW
DBS completes US$1 billion significant risk transfer deal, in first for Singapore bank
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
Singapore private housing is ‘decoupling’ from HDB market as buyer pools diverge: NUS survey
Not in education, employment or training: Why more Hong Kong youths are opting out of work
